先健科技(01302)早盘上涨5.11%,现报1.44港元,成交额708.56万港元。
先健科技发布公告,于2025年2月8日,由中国医学科学院阜外医院舒畅教授领衔,与集团共同研发的主动脉覆膜支架系统获中国国家药品监督管理局正式注册批准。该产品为国家药品监督管理局批准的首款明确适用于烟囱技术的主动脉覆膜支架系统,为累及主动脉弓部病变的患者提供了一种操作简便、安全有效、解剖适应广泛的治疗新选择。
责任编辑:卢昱君
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.